LMAT LeMaitre Vascular Inc.

LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference

LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference

BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at 



Contact:
Sandra Millar
LeMaitre Vascular, Inc.
EN
01/04/2025

Underlying

LMATLeMaitre Vascular Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LeMaitre Vascular Inc.

 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conf...

LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular d...

April 1, 2025 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre to Participate at Upcoming Investor Conferences in March

LeMaitre to Participate at Upcoming Investor Conferences in March BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in March. 37th Annual ROTH ConferenceMonday, March 17, 2025The Laguna Cliffs Marriott, Dana Point, CAManagement will present at 4:00 PM PDT KeyBanc Healthcare ForumWednesday, March 19, 2025Virtual EventManagement will present at 1:30 PM EDT Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceThursday, March 20, 2025Virtua...

March 3, 2025 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre Q4 2024 Financial Results

LeMaitre Q4 2024 Financial Results BURLINGTON, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q4 2024 results, announced an increased quarterly dividend of $0.20/share (+25%), and provided guidance. Q4 2024 Financial Results Sales $55.7mm, +14% (+14% organic) vs. Q4 2023Gross margin 69.3%, +121 bpsOp. income $12.9mm, +26%Op. margin 23%Earnings per diluted share $0.49, +30%Cash up $175.8mm sequentially to $299.7mm Grafts (+23%), carotid shunts (+14%) and catheters (+12%) drove Q4 sales growth. APAC ...

February 27, 2025 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 2...

LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025 BURLINGTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2024 financial results on Thursday, February 27, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online . All registrants will receive dial-in information and a PIN allowing them to access the liv...

January 27, 2025 1 EN
 PRESS RELEASE
Free
LMAT LeMaitre Vascul...

LeMaitre Vascular Prices $150 Million Convertible Senior Notes

LeMaitre Vascular Prices $150 Million Convertible Senior Notes BOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced the pricing of its offering of $150,000,000 aggregate principal amount of 2.50% Convertible Senior Notes due 2030 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes is scheduled to settle on December 19, 2024, subject to customary closing conditions. LeMaitre ...

December 17, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch